Loading...
Header Logo
Keywords
Last Name
Institution

Stavros Stavrakis

TitleAssistant Professor
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Cardiology
Address1200 Everett Dr
Oklahoma City OK 73104-5047
Phone405/271-9696
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stavrakis S, Asad Z, Reynolds D. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Electrophysiol. 2017 Jun; 28(6):659-665. PMID: 28316104.
      View in: PubMed
    2. Garabelli P, Stavrakis S, Po S. Smartphone-based arrhythmia monitoring. Curr Opin Cardiol. 2017 Jan; 32(1):53-57. PMID: 27875477.
      View in: PubMed
    3. Stavrakis S, Stoner JA, Kardokus J, Garabelli PJ, Po SS, Lazzara R. Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study. J Interv Card Electrophysiol. 2017 Jan; 48(1):51-60. PMID: 27696012.
      View in: PubMed
    4. Thanou A, Stavrakis S, Dyer JW, Munroe ME, James JA, Merrill JT. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther. 2016 Sep 02; 18:197. PMID: 27590046; PMCID: PMC5010705.
    5. Stavrakis S, Dyer JW, Koomson E, Scherlag BJ, Bhardwaj B, Lazzara R, Po SS. Spectral Analysis of Baseline Electrocardiogram During Atrial Fibrillation Predicts Response to Antiarrhythmic Drug Therapy in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol. 2016 Aug 10. PMID: 27506321.
      View in: PubMed
    6. Myers JM, Cooper LT, Kem DC, Stavrakis S, Kosanke SD, Shevach EM, Fairweather D, Stoner JA, Cox CJ, Cunningham MW. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight. 2016 Jun 16; 1(9). PMID: 27366791.
      View in: PubMed
    7. Stavrakis S, Dyer JW, Scherlag BJ, Khan Z, Yeung P, Chohan J, Po SS. Spectral Analysis of Electrocardiograms in Patients with Inducible Atrial Fibrillation after Catheter Ablation Predicts Sinus Rhythm Maintenance. Ann Noninvasive Electrocardiol. 2017 Jan; 22(1). PMID: 27226336.
      View in: PubMed
    8. Garabelli P, Stavrakis S, Albert M, Koomson E, Parwani P, Chohan J, Smith L, Albert D, Xie R, Xie Q, Reynolds D, Po S. Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide. J Cardiovasc Electrophysiol. 2016 Jul; 27(7):827-32. PMID: 27027653.
      View in: PubMed
    9. Lignos I, Stavrakis S, Nedelcu G, Protesescu L, deMello AJ, Kovalenko MV. Synthesis of Cesium Lead Halide Perovskite Nanocrystals in a Droplet-Based Microfluidic Platform: Fast Parametric Space Mapping. Nano Lett. 2016 Mar 09; 16(3):1869-77. PMID: 26836149.
      View in: PubMed
    10. Garabelli P, Stavrakis S, Po SS. Ablation of Ventricular Tachycardia in Patients with Ischemic Cardiomyopathy. Card Electrophysiol Clin. 2016 Mar; 8(1):121-9. PMID: 26920180.
      View in: PubMed
    11. Stavrakis S, Humphrey MB, Po SS. Reply: Vagal Modulation of Atrial Fibrillation. J Am Coll Cardiol. 2015 Aug 25; 66(8):978. PMID: 26293771.
      View in: PubMed
    12. Garabelli PJ, Stavrakis S, Po SS. A case series and review of the literature regarding coronary artery complications associated with coronary sinus catheter ablation. HeartRhythm Case Rep. 2015 Sep; 1(5):315-319. PMID: 28491575.
      View in: PubMed
    13. Lignos I, Stavrakis S, Kilaj A, deMello AJ. Millisecond-Timescale Monitoring of PbS Nanoparticle Nucleation and Growth Using Droplet-Based Microfluidics. Small. 2015 Aug 26; 11(32):4009-17. PMID: 25998018.
      View in: PubMed
    14. Stavrakis S, Po SS. Neuroimmunomodulation: A new frontier of treating cardiovascular diseases. Trends Cardiovasc Med. 2016 Jan; 26(1):12-3. PMID: 25983195.
      View in: PubMed
    15. Hess D, Rane A, deMello AJ, Stavrakis S. High-throughput, quantitative enzyme kinetic analysis in microdroplets using stroboscopic epifluorescence imaging. Anal Chem. 2015; 87(9):4965-72. PMID: 25849725.
      View in: PubMed
    16. Stavrakis S, Humphrey MB, Scherlag BJ, Hu Y, Jackman WM, Nakagawa H, Lockwood D, Lazzara R, Po SS. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015 Mar 10; 65(9):867-75. PMID: 25744003; PMCID: PMC4352201.
    17. Stavrakis S, Nakagawa H, Po SS, Scherlag BJ, Lazzara R, Jackman WM. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015 Mar-Apr; 1(1-2):1-13. PMID: 26301262.
      View in: PubMed
    18. Gao M, Zhang L, Scherlag BJ, Huang B, Stavrakis S, Hou YM, Hou Y, Po SS. Low-level vagosympathetic trunk stimulation inhibits atrial fibrillation in a rabbit model of obstructive sleep apnea. Heart Rhythm. 2015 Apr; 12(4):818-24. PMID: 25533582.
      View in: PubMed
    19. Yu L, Dyer JW, Scherlag BJ, Stavrakis S, Sha Y, Sheng X, Garabelli P, Jacobson J, Po SS. The use of low-level electromagnetic fields to suppress atrial fibrillation. Heart Rhythm. 2015 Apr; 12(4):809-17. PMID: 25533588.
      View in: PubMed
    20. Madden G, Farrukh O, Stavrakis S, Sivaram CA. A serendipitous identification of a lead extraction complication. Echocardiography. 2014 Sep; 31(8):E247-9. PMID: 24919764.
      View in: PubMed
    21. Stavrakis S, Jackman WM, Nakagawa H, Sun Y, Xu Q, Beckman KJ, Lockwood D, Scherlag BJ, Lazzara R, Po SS. Risk of coronary artery injury with radiofrequency ablation and cryoablation of epicardial posteroseptal accessory pathways within the coronary venous system. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):113-9. PMID: 24365648.
      View in: PubMed
    22. Patel NH, Golwala H, Stavrakis S, Schechter E. Sertraline-induced ventricular tachycardia. Am J Ther. 2013 Nov-Dec; 20(6):e720-2. PMID: 21768871.
      View in: PubMed
    23. Bhardwaj B, Lazzara R, Stavrakis S. Wide complex tachycardia in the presence of class I antiarrhythmic agents: a diagnostic challenge. Ann Noninvasive Electrocardiol. 2014 May; 19(3):289-92. PMID: 24112534.
      View in: PubMed
    24. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, Hernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013 Aug 21; 2(4):e000214. PMID: 23966379; PMCID: PMC3828812.
    25. Stavrakis S, Patel NH, Reynolds DW. Defibrillation threshold testing does not predict clinical outcomes during long-term follow-up: a meta-analysis. Pacing Clin Electrophysiol. 2013 Nov; 36(11):1402-8. PMID: 23875736.
      View in: PubMed
    26. Wayangankar SA, Patel JH, Patel B, Stavrakis S, Sivaram CA. Clinical and echocardiographic variables associated with LA septal pouch. JACC Cardiovasc Imaging. 2013 Jul; 6(7):833-5. PMID: 23664719.
      View in: PubMed
    27. Thanou A, Ali T, Haq O, Kaitha S, Morton J, Stavrakis S, Humphrey MB. Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease. ISRN Gastroenterol. 2013; 2013:862312. PMID: 23691340; PMCID: PMC3654234.
    28. Garabelli PJ, Stavrakis S. Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy. J Atr Fibrillation. 2013 Apr-May; 5(6):787. PMID: 28496831.
      View in: PubMed
    29. Stavrakis S, Pakala A, Thomas J, Chaudhry MA, Thadani U. Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci. 2013 Mar; 345(3):211-7. PMID: 23422653.
      View in: PubMed
    30. Stavrakis S, Lazzara R. Further insights into the issue of risk stratification of patients with early repolarization. Ann Noninvasive Electrocardiol. 2013 Mar; 18(2):212-3. PMID: 23530494.
      View in: PubMed
    31. Yu L, Scherlag BJ, Li S, Fan Y, Dyer J, Male S, Varma V, Sha Y, Stavrakis S, Po SS. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013 Mar; 10(3):428-35. PMID: 23183191.
      View in: PubMed
    32. Stavrakis S, Scherlag BJ, Fan Y, Liu Y, Mao J, Varma V, Lazzara R, Po SS. Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway. J Interv Card Electrophysiol. 2013 Apr; 36(3):199-208. PMID: 23179922.
      View in: PubMed
    33. Te CC, Stavrakis S, Lozano P, Reynolds D. Apparent acute reversible right ventricular pacing-induced left ventricular dysfunction. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):224-6. PMID: 23131008.
      View in: PubMed
    34. Stavrakis S, Patel N, Te C, Golwala H, George A, Lozano P, Lazzara R. Development and validation of a prognostic index for risk stratification of patients with early repolarization. Ann Noninvasive Electrocardiol. 2012 Oct; 17(4):361-71. PMID: 23094882.
      View in: PubMed
    35. Mao J, Scherlag BJ, Liu Y, Fan Y, Varma V, Stavrakis S, Po SS. The atrial neural network as a substrate for atrial fibrillation. J Interv Card Electrophysiol. 2012 Oct; 35(1):3-9. PMID: 22695762.
      View in: PubMed
    36. Stavrakis S, Garabelli P, Reynolds DW. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace. 2012 Oct; 14(10):1490-7. PMID: 22696519.
      View in: PubMed
    37. Stavrakis S, Scherlag BJ, Fan Y, Liu Y, Liu Q, Mao J, Cai H, Lazzara R, Po SS. Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol. 2012 Jul; 23(7):771-7. PMID: 22487376.
      View in: PubMed
    38. Stavrakis S, Scherlag BJ, Po SS. Autonomic modulation: an emerging paradigm for the treatment of cardiovascular diseases. Circ Arrhythm Electrophysiol. 2012 Apr; 5(2):247-8. PMID: 22511657.
      View in: PubMed
    39. Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow--prevalence and clinical correlations. Circ J. 2012; 76(4):936-42. PMID: 22293446.
      View in: PubMed
    40. Dib C, Hanna EB, Chaudhry MA, Hennebry TA, Stavrakis S, Abu-Fadel MS. Culprit-vessel percutaneous coronary intervention followed by contralateral angiography versus complete angiography in patients with ST-elevation myocardial infarction. Tex Heart Inst J. 2012; 39(3):359-64. PMID: 22719144; PMCID: PMC3368457.
    41. Golwala H, Hawkins BM, Stavrakis S, Abu-Fadel MS. Embolic protection device use and outcomes in patients receiving saphenous vein graft interventions--a single-center experience. J Invasive Cardiol. 2012 Jan; 24(1):1-3. PMID: 22210580.
      View in: PubMed
    42. Yu X, Stavrakis S, Hill MA, Huang S, Reim S, Li H, Khan M, Hamlett S, Cunningham MW, Kem DC. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an "autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012 Jan-Feb; 6(1):40-7. PMID: 22130180; PMCID: PMC3259269.
    43. Stavrakis S, Lazzara R, Thadani U. The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis. J Cardiovasc Electrophysiol. 2012 Feb; 23(2):163-8. PMID: 21815961.
      View in: PubMed
    44. Stavrakis S, Madden G, Pokharel D, Po SS, Nakagawa H, Jackman WM, Sivaram CA. Transesophageal echocardiographic assessment of pulmonary veins and left atrium in patients undergoing atrial fibrillation ablation. Echocardiography. 2011 Aug; 28(7):775-81. PMID: 21752091.
      View in: PubMed
    45. Pappy R, Stavrakis S, Hennebry TA, Abu-Fadel MS. Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis. Int J Cardiol. 2011 Sep 15; 151(3):348-53. PMID: 21636154.
      View in: PubMed
    46. Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011 Jan; 341(1):1-9. PMID: 21191260.
      View in: PubMed
    47. Stavrakis S, Terrovitis J, Tsolakis E, Drakos S, Dalianis A, Bonios M, Koudoumas D, Malliaras K, Nanas J. Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Transl Res. 2011 Feb; 4(1):99-105. PMID: 21153063.
      View in: PubMed
    48. Stavrakis S, Madden GW, Stoner JA, Sivaram CA. Transesophageal echocardiography for the diagnosis of pulmonary vein stenosis after catheter ablation of atrial fibrillation: a systematic review. Echocardiography. 2010 Oct; 27(9):1141-6. PMID: 20678129.
      View in: PubMed
    49. Stavrakis S, Kem DC, Patterson E, Lozano P, Huang S, Szabo B, Cunningham MW, Lazzara R, Yu X. Opposing cardiac effects of autoantibody activation of ß-adrenergic and M2 muscarinic receptors in cardiac-related diseases. Int J Cardiol. 2011 May 05; 148(3):331-6. PMID: 20053466; PMCID: PMC3108570.
    50. Schwartz JJ, Stavrakis S, Quake SR. Colloidal lenses allow high-temperature single-molecule imaging and improve fluorophore photostability. Nat Nanotechnol. 2010 Feb; 5(2):127-32. PMID: 20023643; PMCID: PMC4141882.
    51. Stavrakis S, Yu X, Patterson E, Huang S, Hamlett SR, Chalmers L, Pappy R, Cunningham MW, Morshed SA, Davies TF, Lazzara R, Kem DC. Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol. 2009 Sep 29; 54(14):1309-16. PMID: 19778674; PMCID: PMC2801559.
    52. Yu X, Patterson E, Stavrakis S, Huang S, De Aos I, Hamlett S, Cunningham MW, Lazarra R, Kem DC. Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors. J Am Soc Hypertens. 2009 Mar-Apr; 3(2):133-40. PMID: 20409953; PMCID: PMC3116651.
    53. Kem DC, Yu X, Patterson E, Huang S, Stavrakis S, Szabo B, Olansky L, McCauley J, Cunningham MW. Autoimmune hypertensive syndrome. Hypertension. 2007 Nov; 50(5):829-34. PMID: 17923587; PMCID: PMC3127442.
    54. Daskalakis V, Pinakoulaki E, Stavrakis S, Varotsis C. Probing the environment of cu(b) in heme-copper oxidases. J Phys Chem B. 2007 Sep 06; 111(35):10502-9. PMID: 17696387.
      View in: PubMed
    55. Tiniakos D, Anagnostou V, Stavrakis S, Karandrea D, Agapitos E, Kittas C. Ontogeny of intrinsic innervation in the human kidney. Anat Embryol (Berl). 2004 Nov; 209(1):41-7. PMID: 15480775.
      View in: PubMed
    56. Koutsoupakis C, Pinakoulaki E, Stavrakis S, Daskalakis V, Varotsis C. Time-resolved step-scan Fourier transform infrared investigation of heme-copper oxidases: implications for O2 input and H2O/H+ output channels. Biochim Biophys Acta. 2004 Apr 12; 1655(1-3):347-52. PMID: 15100050.
      View in: PubMed
    57. Koutsoupakis K, Stavrakis S, Soulimane T, Varotsis C. Oxygen-linked equilibrium CuB-CO species in cytochrome ba3 oxidase from thermus thermophilus. Implications for an oxygen channel ar the CuB site. J Biol Chem. 2003 Apr 25; 278(17):14893-6. PMID: 12594218.
      View in: PubMed
    58. Pinakoulaki E, Stavrakis S, Urbani A, Varotsis C. Resonance Raman detection of a ferrous five-coordinate nitrosylheme b(3) complex in cytochrome cbb(3) oxidase from Pseudomonas stutzeri. J Am Chem Soc. 2002 Aug 14; 124(32):9378-9. PMID: 12167025.
      View in: PubMed
    59. Koutsoupakis K, Stavrakis S, Pinakoulaki E, Soulimane T, Varotsis C. Observation of the equilibrium CuB-CO complex and functional implications of the transient heme a3 propionates in cytochrome ba3-CO from Thermus thermophilus. Fourier transform infrared (FTIR) and time-resolved step-scan FTIR studies. J Biol Chem. 2002 Sep 06; 277(36):32860-6. PMID: 12097331.
      View in: PubMed
    60. Stavrakis S, Koutsoupakis K, Pinakoulaki E, Urbani A, Saraste M, Varotsis C. Decay of the transient Cu(B)-CO complex is accompanied by formation of the heme Fe-CO complex of cytochrome cbb(3)-CO at ambient temperature: evidence from time-resolved Fourier transform infrared spectroscopy. J Am Chem Soc. 2002 Apr 17; 124(15):3814-5. PMID: 11942802.
      View in: PubMed
    Stavrakis's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _